The spread of the new coronavirus is on its way of competing with other pandemics in the history of humanity if we look at the number of infections. The daily cases in the United States are way off the charts, as there’s a significant increase in the number of infections during the last weeks. As for the overall situation in the world, things are looking pretty bad: 12.6 million infections and over 560,000 deaths.
While scientists had been struggling to develop a vaccine for the disease within labs all over the world, the best weapon could have already been available for us all the time. The tuberculosis vaccine Bacillus Calmette-Guerin (BCG) is suspected of working against COVID-19 as well, and new research emerges to support the hypothesis.
BCG draw the attention of WHO
The World Health Organisation doesn’t rule out the idea of the tuberculosis vaccine to be efficient against COVID-19, but it has cautioned against its use until scientists gather more knowledge about the idea.
Researchers are relying on the fact that certain countries had less mortality from the new coronavirus where their people received the BCG vaccine. The conclusion was made by Luis Escobar of Virginia Polytechnic Institute and his colleagues. Other research claims that the vaccine can improve the immune system of those that receive it, and so there’s a chance that it can help against COVID-19 as well.
Overall, the best way to not be affected by COVID-19 is by definition to not get the disease at all. And it’s totally feasible if you respect several simple measures like frequently washing your hands, not pretending to wear your facemask, maintaining a decent distance from people who sneeze or cough, and avoid crowds.
The new findings were reported in the journal Proceedings of the National Academy of Sciences.
James is passionate about mobile gadgets, and he likes to keep himself up-to-date with the latest releases in the field of smartphones, tablets, and so on. He has ten-year experience in writing content and reviewing tech products. For Meedios, James will cover news regarding mobile devices, mobile operating systems, and more.